Ticker Details
Foghorn Therapeutics Inc.
IPO Date:	October 23, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$419.85M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.36 | 4.21%
Avg Daily Range (30 D):	$0.19 | 3.34%
Avg Daily Range (90 D):	$0.17 | 3.47%

Institutional Daily Volume
Avg Daily Volume:	.13M
Avg Daily Volume (30 D):	.23M
Avg Daily Volume (90 D):	.18M

Trade Size
Avg Trade Size (Sh.):	84
Avg Trade Size (Sh.) (30 D):	71
Avg Trade Size (Sh.) (90 D):	62

Institutional Trades
Total Institutional Trades:	89
Avg Institutional Trade:	$1.52M
Avg Institutional Trade (30 D):	$.59M
Avg Institutional Trade (90 D):	$1.76M
Avg Institutional Trade Volume:	.14M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.5M
Avg Closing Trade (30 D):	$.59M
Avg Closing Trade (90 D):	$1.83M
Avg Closing Volume:	232.32K

News

Jul 1, 2026 @ 11:00 AM Step Pharma announces the appointment of Neil Gall... Source: Step Pharma

Apr 9, 2026 @ 11:00 AM Foghorn Therapeutics to Present New Preclinical Da... Source: Na

Jan 14, 2026 @ 3:52 PM Precision Killers: Why Big Pharma is Betting Billi... Source: Prnewswire

Jan 10, 2026 @ 3:20 AM Foghorn Therapeutics Highlights January Equity Fin... Source: Na

Nov 17, 2025 @ 11:00 AM 4DMT Appoints Kristian Humer as Chief Financial Of... Source: 4D Molecular Therapeutics

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.98	$-.1	$-.29
Diluted EPS	$-.98	$-.1	$-.29
Revenue	$36.74M	$16.07M	$3.27M
Gross Profit
Net Income / Loss	$-64.58M	$-7.19M	$-19.88M
Operating Income / Loss	$-72.76M	$-8.81M	$-21.57M
Cost of Revenue
Net Cash Flow	$-5.74M	$-20.83M	$6.79M
PE Ratio